Enhabit Inc Q4 2024 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Brian Tanquilut - Jefferies LLC - Analyst : Hey. Good morning. Maybe Barb, as I think about the momentum that we've seen you guys deliver in Q4, just curious how you're thinking about that carrying over into 2025, especially now that you have the BD team built out and then maybe related to that just that what are your thoughts on fee for service and your ability to gain share there going forward?

Question: Brian Tanquilut - Jefferies LLC - Analyst : Got it. And then maybe as I think about your comments and in the press release about the payer innovation contract and then your preparing partner remarks as well, what kind of visibility do you have there and how are you thinking about the leverage that you have to convert non-payer contracts into better paying deals with MA plans.

Question: Ryan Langston - TD Cowen - Analyst : Thanks. Good morning. Maybe to follow up on Brian's question on the home health payer innovation side, I think in the slides you have 49 new opportunities, 31 historical agreements you're renegotiating. How does that relate back to '25 guidance. I guess, is there some potential maybe upside to the guide depending on how the outcome of those negotiations happen?

Question: Ryan Langston - TD Cowen - Analyst : Got it. And then just last one for me, the hospice revenue per day was up pretty nicely despite a pretty tough comp from last year. I think Ryan, you said maybe some benefit from hospice cap accruals versus the third quarter. Anyway, you could break down sort of the components between maybe sort of true rate and what those accruals were. Thanks.